News | Hypertension | November 11, 2015

AHA, AMA Call for Higher Priority on Blood Pressure Control

Evidence shows uncontrolled high blood pressure contributes to major health issues; latest research supports lower blood pressure targets to improve heart health

high blood pressure, Target BP, AMA, AHA, American Heart Association, American Medical Association

November 11, 2015 — Two of the country’s preeminent health organizations, the American Heart Association (AHA) and the American Medical Association (AMA), announced a new nationwide initiative aimed at addressing the growing burden of high blood pressure in the United States.

Target: BP will support physicians and care teams in helping their patients with high blood pressure reach a blood pressure goal of lower than 140/90 mm Hg, based on current AHA guidelines.

Although Target: BP is the first major collaborative initiative between the AHA and AMA, both organizations have long recognized high blood pressure as a major health threat. Both already have a number of practice- and community-based initiatives and online tools that are helping physicians improve blood pressure control among their patients and helping people understand and improve their high blood pressure. They’ll now synergize these efforts into a campaign that will further assist both providers and patients by enhancing high blood pressure awareness, understanding and management.

As part of Target: BP, hospitals, medical practices, practitioners and health services organizations will work to raise awareness about high blood pressure and commit to high levels of control in their patient populations. Participants will work with the latest AHA guidelines on blood pressure, aiming for readings of lower than 140/90 mm Hg for each patient, with goals adjusted as new data drives any guideline revisions in the future. AHA and AMA will provide these groups with tools and resources, including the AHA/ACC/CDC Hypertension Treatment Algorithm, for achieving this goal and will recognize those who attain high levels of control.

Even prior to the official launch, more than 50 healthcare systems or clinics serving nearly 18 million people quickly committed to participate in Target: BP, and additional ones are poised to join.

One in three American adults — about 80 million people — has high blood pressure and that number is steadily climbing, despite the fact that high blood pressure can usually be easily treated. There is a substantial body of evidence showing that high blood pressure is a contributing factor to many major health conditions, including heart attack, heart failure, stroke, kidney failure and other disease consequences.

Data from the landmark Systolic Blood Pressure Intervention Trial (SPRINT) supports recommendations for keeping blood pressure low. The final results of SPRINT are being presented this week at the AHA’s Scientific Sessions, but previously reported preliminary findings indicated that reducing systolic blood pressure to 120 mm Hg among study participants markedly reduced the combined rate of having a heart attack, acute coronary syndrome, heart failure or stroke and reduced mortality. The study was sponsored by the National Institutes of Health and examined more than 9,300 people.

AHA President Mark Creager, M.D., said the SPRINT data is being systematically examined by the AHA/ACC Hypertension Guideline Writing Committee in consideration of any guideline revisions.

 “The SPRINT results underscore our long-standing position to detect and aggressively treat people with high blood pressure,” said Creager, director of the Heart and Vascular Center at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire “Currently, only about half of Americans with high blood pressure are achieving our recommended blood pressure reading of below 140/90 mm Hg. With Target: BP, we’ll equip healthcare providers and their patients with information and tools, to help keep blood pressure under control. By controlling blood pressure, we can potentially prevent progression to other serious threats to heart and brain health.”

 “For several years, the AMA has been keenly focused on the millions of Americans who have uncontrolled hypertension,” said AMA President Steven J. Stack, M.D. “This new collaboration will significantly build on the work we’ve already begun to improve cardiovascular health. As an emergency physician, I’ve seen first-hand the devastating impact of heart disease and I’m personally proud to be a part of a national effort that will not only save lives but help people live healthier and happier lives.”

 While fewer Americans are dying from heart disease and stroke, deaths caused by high blood pressure are on the rise, increasing 13 percent between 2001 and 2011. High blood pressure is also associated with significant economic impact, costing Americans an estimated $46 billion annually in healthcare services, medications and missed days of work

“We recognize the threat of uncontrolled blood pressure and certainly need to do a better job in helping our patients achieve blood pressure targets with lifestyle modifications as well as ideal medical therapy,” said Daniel Simon, M.D., division chief of cardiovascular medicine at UH Case Medical Center and president of the Harrington Heart and Vascular Institute at University Hospitals in northeast Ohio, an early adopter of the initiative. “Bringing evidence-based treatment approaches to our practices through Target: BP is a simple, effective way to help us renew our focus on blood pressure and bring more patients to their idea goal.”

For more information:

Related Content

BackBeat Cardiac Neuromodulation Therapy Shows Immediate, Substantial Blood Pressure Reduction
News | Hypertension | June 04, 2019
Orchestra BioMed Inc. announced the presentation of two-year clinical data from the European Moderato I study of...
St. Bartholomew's Hospital Initiates CALM-2 Hypertension Trial
News | Hypertension | February 20, 2019
California-based Vascular Dynamics Inc. (VDI) is sponsoring a new clinical trial, called CALM-2 (Controlling And...
Research Sheds Light on Blood Pressure Drug Function
News | Hypertension | January 31, 2019
Researchers have mapped the active-state structure of the angiotensin II type 1 receptor, the target of widely...
Hypertension With Progressive Cerebral Small Vessel Disease Increases Cognitive Impairment Risk
News | Hypertension | January 08, 2019
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of...
Barbershop Intervention Continues to Lower Blood Pressure at One Year
News | Hypertension | December 27, 2018
African-American men participating in a blood pressure reduction program implemented in barbershops continued to have...
Analytics 4 Life and Actelion to Develop New Diagnostics for Pulmonary Hypertension
News | Hypertension | December 14, 2018
Digital health company Analytics 4 Life and Actelion Pharmaceuticals Ltd. announced a collaborative agreement to...
Hypertensive Crisis Five Times More Likely Among Blacks, according to a late-breaking study at AHA 2018. #AHA #AHA18 #AHA2018
News | Hypertension | November 13, 2018
Black adults experience dangerous spikes in high blood pressure, called a hypertensive crisis, at a rate that is five...
Home Monitoring Confirms Clinic Diagnosis of High Blood Pressure
News | Hypertension | October 29, 2018
Blood pressure readings of 130/80 millimeters of mercury (mmHg) or higher taken at home can be used to diagnose...
 Pulmonary artery denervation for CpcPH from the PADN-5 trial. #TCT2017

A series of procedural images of a pulmonary artery denervation for CpcPH from the PADN-5 trial.

News | Hypertension | October 04, 2018
October 4, 2018 — Pulmonary artery denervation (PADN) is associated with significant improvements in hemodynamic and
Overlay Init